Reply  by Salles-Cunha, Sergio
the preoperative extent of the SVN, the possibility of pre-existing
SVN cannot be excluded, especially when the duplex ultrasound
method was not identical before and after surgery, with postoper-
ative setting optimization meant to maximize sensitivity.
In fact, many small vessels can be identified with ultrasonog-
raphy before any treatment, and there is no reason that RF ablates
them. For example, the external pudendal artery visible in contact
with the GSV termination in preoperative ultrasound examination
remains discernible after RF, in contact with the occluded GSV.
Similarly, it is common to visualize arterioles close to the GSV
during ultrasonography-guided sclerotherapy (Figure). Consider-
ing these arterioles as SVN, they cannot be attributed to neovas-
cularization. Regarding the veins, it is known that the saphe-
nofemoral junction (SFJ) tributaries, which are also covered by the
SVN definition, remain patent after RF in more than 90% of cases.1
Therefore, it is not surprising that the authors found a lower
prevalence of SVN when a high ligation was performed. It would
have been helpful for the authors to provide a more anatomically
precise SVN classification. It is difficult to assign an identical
pathologic effect to vessels so anatomically different as arterioles
and refluxing or not refluxing veins. In our experience, refluxing
veins observed after RF—excepting the cases of recanalization or
nonocclusion—involve only the low SFJ tributaries or the groin
ganglionic veins.
The persistence of a short patent segment at the termination of
the GSV is a known pattern, consistent with the endovenous
therapeutic concept that allows physiologic drainage of the SFJ
collaterals toward the deep system.2 However, the prognosis of
GSV termination recanalization in case of associated high ligation
should be more pejorative because of the possibility of physiologic
drainage of the recanalized GSV is suppressed. The rate of GSV
trunk recanalization in this study (35%) is much higher than
previously reported (9.5% at 2 years and 11.5% at 4 years).2,3
Knowing that only 20% of the GSVs with partial occlusion or
nonocclusion are refluxing, it is not obvious that the network
including the feeding vein, the recanalized GSV, and the draining
vein observed by the authors was inconsistent with a physiologic
circulation, especially in the absence of reflux.
Because the endovenous treatment concept is very different
from conventional surgery, it is mandatory to attentively assess the
results of RF. Ensuring an identical preoperative and postoperative
ultrasound method to establish consistent conclusions is also nec-
essary.
Olivier Pichot, MD
Denis Creton, MD
Chu de Grenoble
Grenoble, France
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Reply
We did not suggest a very high neovascularization rate after
radiofrequency ablation (RFA) of the great saphenous vein. We did
discuss a possible connection between what other authors called
neovascularization and what we prefer to name small vessel net-
works. A major reason why we selected small vessel network was to
avoid the connotation associated with the concept of neovascular-
ization. Our intention was also to critique the use of the term
neovascularization without proof that these vessels did not exist
before. For one reason, existing small vessels may dilate in response
to an inflammatory process and may constrict after the inflamma-
tion subsides. Clinically, thrombosis may occur in the postopera-
tive period in untreated segments proximal and distal to the
segment exposed to the RFA and also within the treated segment.
Furthermore, patients have complained of localized pain or dis-
comfort starting months after a successful RFA. This localized pain
was associated with a visible vein valve sinus either totally throm-
bosed or partially recanalized; pain was associated with a thrombus
that seemed hypoechoic enough to be considered recent. There is
growing evidence associating the appearance of small vessels, in-
cluding arterialized flow, with thrombus.
In our articles, we also made the distinction between recana-
lization and reflux. The term recanalization was preferred to avoid
the clinical inference associated with the concept of reflux. At early
stages of recanalization, clinical reflux is commonly absent. This
recanalization can be temporary and limited in length. (A reason
why recanalization was higher in this series than previously re-
ported may be that we considered recanalization segments as short
as 1 or 2 cm occurring at any level.) An unstable cycle of throm-
bosis, inflammation, thrombolysis, recanalization, reduction of
inflammation, low-flow condition, and then new thrombosis has
been suspected. Eventually the recanalization either becomes wide
enough to be part of a local network of small vessels or thrombosis
dominates, and, with thrombus aging, the vein segment becomes
atretic and atrophic and eventually disappears as such, becoming
unrecognizable by ultrasonography.
We also have described small vessel networks associated with
telangiectasias. It is not surprising to detect small vessel networks
in these patients before or after treatment of the saphenous vein.
Figure. Pretreatment duplex image showing collateral veins and
arteries close to the refluxing great saphenous vein (GSV) trunk.
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Patients have described the appearance of new telangiectasias after
saphenous vein treatment, RFA, or stripping. We have connected
the appearance of such new telangiectasias to the small vessels
surrounding thrombosed, treated segments of the saphenous vein,
mostly large vein valve sinuses. Small vessel networks can also be
noted around thrombus inside the canal previously occupied by a
stripped saphenous vein. Rather than dismiss the findings of small
vessel networks noted after treatment of the saphenous vein, we
should investigate whether and when the presence of these chan-
nels has a clinical effect. The first step was to recognize the presence
of such small vessel networks.
Sergio Salles-Cunha, PhD
Clinical Research Director
Jobst Vascular Center
Toledo, Ohio
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Regarding: Carotid endarterectomy in patients
with chronic renal insufficiency: A recent series of
184 cases
We read with interest the article by Ascher et al (J Vasc Surg
2005;41:24-9) about early outcome of 184 internal carotid artery
endarterectomy procedures in 166 patients with chronic renal
insufficiency (CRI). These patients with CRI (serum creatinine
level 1.5 mg/dL) accounted for 27% of all patients undergoing
endarterectomy, a proportion much higher than in our own expe-
rience of 4.6% based on the same criterion (146/3157 patients
during 1990 to 2002). We believe that the higher risk of postop-
erative death associated with severe CRI, as shown by Ascher et al,
should limit the indication for surgery, especially in asymptomatic
patients on dialysis. Many vascular surgeons have intuitively ap-
plied that restriction. However, as shown by Reil et al,1 the
neurologic risks associated with endarterectomy are similar in
patients with CRI and normal renal function. Rather, it is cardiac
complications that are the most serious threat for death in these
patients.
Regretfully, Ascher et al failed to give details about the five
deaths that occurred in their series. However, in the meeting
discussion accompanying the article, the authors stated that two
deaths were due to myocardial infarction, one due to multiple
organ failure triggered by an unknown cause, one due to broncho-
pulmonary aspiration (neurologic status not specified), and one
due to postoperative stroke. This stroke-related death shows that it
would have been useful to do a thorough analysis of mortality
rather than to speculate about the potential role of protamine or
hemodynamic disturbances observed after dialysis sessions.
The article and meeting discussion also revealed an ambiguity
towards cardiac work-up. In the article, the authors suggest that
rigorous cardiac assessment is necessary even in asymptomatic
patients. In the discussion, they argue against such work-up by
stressing the morbidity of “open heart” surgery. It is unclear why
they would rule out the possibility of treating coronary artery
lesions screened by percutaneous angioplasty.
Patients with CRI must be considered a high-risk group for
carotid endarterectomy because of mortality rather than stroke
risk. In this regard, they may be better candidates for carotid
stenting, like those patients with advanced heart disease included
in the SAPPHIRE study.2 Further study would be necessary to
demonstrate the safety and long-term efficacy of such an approach.
Until then, our approach is to be very conservative in recommend-
ing carotid endarterectomy for patients with CRI, especially the
asymptomatic cohort.
Laurent Chiche, MD
Fabien Koskas, MD
Edouard Kieffer, MD
Pitié-Salpetrière University Hospital
Department of Vascular Surgery
Paris, France
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Thank you for your comments regarding our paper concern-
ing carotid endarterectomy in patients with chronic renal insuffi-
ciency (CRI). We agree with you that a more thorough assessment
of the cause of death postcarotid endarterectomy in these patients
would have been of value. However, upon reviewing the medical
records of the patients who died postoperatively, we were unable to
uncover a common denominator. We did speculate about the role
of protamine and also the hemodynamic disturbances that may
occur during hemodialysis, because these are known facts associ-
ated with increased mortality.
It is our opinion that coronary bypass surgery in patients with
severe CRI should be limited because of the associated increased
mortality and morbidity. Whether percutaneous coronary artery
balloon angioplasty is of value to these patients remains to be
proven.
Also, we agree with your comments that carotid endarterec-
tomy should not be liberally used in asymptomatic patients with
severe CRI. It will be interesting to see whether carotid artery
balloon angioplasty and stenting would be of benefit for this
cohort of patients in the long-term.
We appreciate your taking the time to read our paper and ask
reasonable questions.
Enrico Ascher, MD
Maimonides Medical Center
Brooklyn, NY
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